Actively Recruiting

Age: 18Years +
All Genders
NCT06843512

Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication

Led by Penn State University · Updated on 2025-09-10

25

Participants Needed

1

Research Sites

72 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

In recent years, GLP-1 medications have become a widely employed approach by physicians to address weight concerns in patients and lead to weight loss. Little is known, however, about how these medications may alter an individual's attitude towards food, food reactivity, or the specific types and amounts of foods an individual will choose. The purpose of this study is to observe the changes an individual experiences in their relationship and reaction to food and in their food selection prior to or within the first two weeks of taking GLP-1 medication to after three months on the medication. The researchers of this study believe that an understanding of such changes can inform questions seeking to ensure maintenance of appropriate nutrient balance within individuals on weight loss medications.

CONDITIONS

Official Title

Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years or older with overweight or obesity (BMI >25 kg/m2)
  • Not currently taking an incretin-based medication at baseline
  • Recently prescribed a GLP-1 medication within two weeks prior to study start
  • May have obesity-related conditions such as diabetes, hypertension, cardiovascular disease, or dyslipidemia
  • No prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy
  • Fluent in English
Not Eligible

You will not qualify if you...

  • Adults without overweight or obesity
  • Under 18 years of age at time of testing
  • Not taking a GLP-1 medication
  • Taking a compound GLP-1 medication
  • On GLP-1 medication for longer than two weeks at baseline
  • Prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy
  • Not fluent in English

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Health, Ingestive Behavior, and Technology Laboratory of Pennsylvania State University

State College, Pennsylvania, United States, 16802

Actively Recruiting

Loading map...

Research Team

C

Christina M Blackmon

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication | DecenTrialz